Prime Prostate Care
Natural health product licensed in Canada
- Other names
- Dr Nutrition Prime Prostate Care, Maplelife Nutrition Prime Prostate Care
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80059177
- Status
- Active licence
- Licence date
- 25 March 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 100 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 20 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 640 mg Potency : 45 % Fatty acids | 64 mg | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 300 mg Potency : 0.8 % beta-Sitosterol | 60 mg | Not calculated |
| Cucurbita pepo Source : Cucurbita pepo - Graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 160 mg | 40 mg | Not calculated |
| Vitis Vinifera Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 250 mg Potency : 85 % Oligomeric proanthocyanidins | 125 mg | Not calculated |
| Isatis tinctoria Source : Racine | 40 mg | Not calculated |
| Sélénium Source : Citrate de sélénium | 50 mcg | 100 µg |
| Prunus africana Source : Écorce (tige) Potency : 12 % Phytosterols | 38 mg | Not calculated |
| Prunus africana Source : Ecorce (tronc) Potency : 12 % Phytosterols | 38 mg | Not calculated |
| Phytostérols Source : Phytosterols Potency : 40 % beta Sitosterol | 230 mg | Not calculated |
| Zinc Source : Citrate de zinc | 10 mg | 20,000 µg |
Non-medicinal ingredients
Gélatine, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Helps reduce the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with benign prostatic hyperplasia. Source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. To exclude the diagnosis of prostate cancer, consult a health care practitioner prior to use.
- Contre-indications
Do not exceed the recommended dose except on the advice of a physician.
Source
Official Health Canada record, licence 80059177
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.